Table 4.
Logistic regression models for dynapenia in hospitalized cancer patients
| Crude OR (IC95%) |
Model 1 OR (IC95%) |
Model 2 OR (IC95%) |
Model 3 OR (IC95%) |
Model 4 OR (IC95%) |
|
|---|---|---|---|---|---|
| DAPMT (mm) | |||||
| Adequate | 1 | 1 | 1 | 1 | 1 |
| Reduced | 4.65 (1.88–11.48) | 4.70 (1.03–22.0) | 5.13 (1.05–25.10) | 5.86 (1.10–31.06) | 5.54 (1.04–29.39) |
| NDAPMT (mm) | |||||
| Adequate | 1 | 1 | 1 | 1 | 1 |
| Reduced | 3.10 (1.30–7.38) | 1.22 (0.26–5.62) | 1.14 (0.24–5.44) | 0.84 (0.15–4.49) | 1.02(0.20–5.30) |
| BMI (kg/m2) | |||||
| Eutrophy | 1 | 1 | 1 | 1 | 1 |
| Low weight | 5.17 (2.02–13.26) | 5.66 (2.01–3.31) | 4.17 (1.42–12.25) | 4.83 (1.58–14.71) | 4.55(1.47–14.08) |
| Overweight | 0.66 (0.21–2.05) | 1.00 (0.30–3.31) | 1.14 (0.24–5.44) | 1.02 (0.30–3.47) | 1.12(0.32–3.94) |
Model 1: adjusted for gender. Model 2: adjusted for gender and stage of life. Model 3: adjusted for gender, stage of life and color Model 4: adjusted for gender, stage of life, color, malnutrition (PG-SGA) and cachexia. BMI Body mass index, DAPMT dominant adductor pollicis muscle thickness, NDAPMT Non-dominant adductor pollicis muscle thickness. The numbers in bold indicate those where p < 0.05